ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Intercultural Cancer Council Endorses New NCI Office

July 5, 1996

Risk Assessment Key In Long-Term Treatment

August 29, 2008

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

Addendum to RAID

December 17, 1999

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977

Congress Holds Recision Hearings

February 28, 1975